World Drug Tracker

Tracks information on drugs on worldwide basis by Dr Anthony Melvin Crasto, helping millions with websites, 9 million hits on google, 2.5 lakh connections worldwide, P.S. : The views expressed are my personal and in no-way suggest the views of the professional body or the company that I represent.

Pages

Home
Disclaimer
About me
Polymorphism
Clinical Trials
DRUG PORTALS
INDA
Routes of admin'n of drugs
Naming a drug
Computational Chemistry
Icons
china links
CANCER
GUIDELINES
GMP LINKS
ANAL LINKS
HOMEOPATHY
New drug approvals
All about drugs
PHARMA BOOKS
Six Sigma Blogs:

Friday, 28 June 2013

Celgene buys MophoSys for myeloma antibody development

Celgene buys MophoSys for myeloma antibody development
German biopharmaceutical company MorphoSys will jointly develop an antibody for the treatment of multiple myeloma (MM) and leukaemia with Celgene Corporation.

http://www.pharmaceutical-technology.com/news/newscelegene-buys-mophosys-for-myeloma-antibody-development?WT.mc_id=DN_News

Posted by DRUG PATENTS INTERNATIONAL at 09:17

Email This BlogThis!Share to X Share to Facebook Share to Pinterest

Labels: anthony crasto, ayurveda, DRUGS, herbs, medicinal chemistry, New Drugs, organic chemistry, ORGANIC SYNTHESIS, PATENTS, POLYMORPHISM, process, world drug tracker

No comments:

DR ANTHONY MELVIN CRASTO

MY BLOGS ON MED CHEM

New Drug Approvals,

ALL ABOUT DRUGS,

WORLD DRUG TRACKER,

MEDICINAL CHEMISTRY INTERNATIONAL,

DRUG SYN INTERNATIONAL

SCALEUP OF DRUGS,

ALL FOR DRUGS,

EUREKAMOMENTS,

and my new blog API SYNTHESIS INTERNATIONAL

SEARCH THIS BLOG, WORLD DRUG TRACKER

ORGANIC SPECTROSCOPY

Read all about Organic Spectroscopy on ORGANIC SPECTROSCOPY INTERNATIONAL

Translate

JOIN ME

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO .....FOR BLOG HOME CLICK HERE

Join me on Linkedin

Join me on Facebook

FACEBOOK

Join me on twitter

Join me on google plus

Googleplus

amcrasto@gmail.com

Total Pageviews

Revolver map

IP ADDRESS

VISITORS IP ADDRESS

IP Address

Join me-Do not miss me

amcrasto@gmail.com

............Join me on Linkedin

Anthony Melvin Crasto Ph.D - India | LinkedIn

join me on Researchgate

Anthony Melvin Crasto Dr. | ResearchGate

join me on Facebook

Anthony Melvin Crasto Dr. | Facebook

FACEBOOK

join me on twitter a

Anthony Melvin Crasto Dr. | twitter

Twitter

join me on google plus

Anthony Melvin Crasto Dr. | google plus

GOOGLE PLUS

Subscribe To

Posts

Atom

Posts

Comments

Atom

Comments

Followers

Blog Archive

► 2023 (1)
- ► March (1)

► 2020 (2)
- ► November (1)
- ► September (1)

► 2018 (1)
- ► May (1)

► 2017 (1)
- ► December (1)

► 2016 (29)
- ► October (1)
- ► August (2)
- ► July (2)
- ► June (9)
- ► May (3)
- ► April (2)
- ► March (2)
- ► February (3)
- ► January (5)

► 2015 (53)
- ► December (7)
- ► November (2)
- ► September (1)
- ► July (8)
- ► June (1)
- ► May (4)
- ► April (7)
- ► March (10)
- ► February (4)
- ► January (9)

► 2014 (268)
- ► December (4)
- ► November (6)
- ► October (10)
- ► September (9)
- ► August (22)
- ► July (13)
- ► June (29)
- ► May (7)
- ► April (45)
- ► March (31)
- ► February (31)
- ► January (61)

▼ 2013 (531)
- ► December (52)
- ► November (71)
- ► October (96)
- ► September (74)
- ► August (16)
- ► July (35)
- ▼ June (57)
- ► May (130)

About Me

DRUG PATENTS INTERNATIONAL

View my complete profile

facebook

Anthony Melvin Crasto likes

Organic Chemistry Select

Create your Like Badge

FB FLOAT

SMART

Labels

(–)-18-Methoxycoronaridine (18-MC) (±)-Integrifolin (R)-Niguldipine hydrochloride 11-12 November 2016 1233855-46-3 123794 1627748-32-6 1R 2015 4-b]furan-8-yl]ethyl}acetamide 4S Transnorsertraline 5975-SMB GC-MS 6-dihydro-2H-indeno[5 A Case a CENP-E Inhibitor Abdominal Fat Abilify Achillion ACS Symposium ACTAVIS ACTIVATORS OF GUANYLYL CYCLASE Adenosine Receptor Agonist Adlyxin Afema Afinitor aids AKR leukemia Aldoxorubicin Alexza alkenyl trifluoroborates ALLEPPEY Allisartan isoproxil Aloe vera ALOSETRON Altaf Ahmed Lal amg 837 AMG 925 Amgen An Illustrated Dictionary ANAMORELIN andarine ANIDULAFUNGIN Anoro Ellipta anthony crasto anti-inflammatory agents Antiarrhythmic antibiotics antibodies Antibody-Free anticancer Anticancer Agent anticancer drug ANTIMALARIAL Antimalarial Drug antipsychotic antirheumatic agent. antiviral activity aphrodiasic aphrodisiacs api apixaban Aplastic Anemia APOIIIRx Approval Approves APREMILAST aptamers argatroban arGEN-X Aripiprazole Arnuity Artemisia annua Extract Artemisini ARTESUNATE Arthritis Asfotase alfa Asparagusic acid ASPARGUS ATL1102 atmospheric air Atractylodes ATX-101 Aubagio aurobindo Autoradiography avanafil Avibactam AVOSENTAN ayurveda AZASETRON Bai Zhu BARDOXOLONE BAVITUXIMAB Baxalta U.S. BAY 63-2521 Bay-12-8039 bayer ag BELINOSTAT Beloranib BENAZEPRIL HYDROCHLORIDE beraprost Bergman Cyclization BEZ 235 bhasma BI 201302 BIA 10-2474 Biafungin biobattery Bioengineering Biolimus biosensors biosimilarm Zarxio biosimilars biotech Biotechnological pharmaceuticals BITTER COLA bleeding episodes Blinatumomab BLOG Blood cancers Boehringer-Ingelheim BORTEZOMIB breast breast cancer Bremelanotide BRINAVESs Brintellix Burdock Burixafor Buserelin CADAZOLID CAL 101 California. CANADA CANCER cangrelor Cannabidiol CANTHARIDIN cas CASOPITANT catalyst catalysts CD 101 cephalosporins Cerdelga Cervarix two-dose schedule CETP inhibition CHEMDRAW PRO 8.0 chemistry and application china Chinese Medicine Chinese-Made Drug Substances chocolate cholesterol cholesterol ester transfer protein Chromatography Fractions chronic Chronic Obstructive Pulmonary Chūō Cicaprost CIDOFOVIR ciloprost ciluprevir CINACIGUAT cinnamon Cipargamin CIPROSTENE citrate lyase clazosentan Click reaction Clinical Trial Tragedy Clinical Trials Clostridium difficile Vaccine CNS co-crystals Coconut Oil cocrystals Cold EI Coming Home complex fluidized-bed granulator computers Continuous COPD Crystallization CS-3150 CV Therapeutics CVT-510 dabigatran Daclatasvir Dactolisib daglutril Dandelion DAPAGLIFLOZIN Daphine (Daphne gnidium) DASANTAFIL Dasotraline Decernotinib degarelix delamanid deldeprevir. neceprevir Deliver Potential Depression Detection Dexniguldipine hydrochloride diabetes diabetes No Responses » Edit Jul 032015 diagnose Digestive Miracle discovery Disease dissolution DNA Damage DOLASETRON dolutegravir Dorzolamide Hydrochloride doxofylline Dr Anthony Crasto dr reddys Dr. Nayana P Hegde drngue drug drug and alcohol abuse DRUG APPORVALS Drug Delivery drug design drug discovery drug market. India Drug-drug co-crystals DRUGS drying ability ds 8587 dulaglutide duvelisib early clinical drug development stages economical eculizumab edoxaban egypt elacytarabin eliglustat Eliquis Ellipta elosufase alfa) Elotuzumab Elpamotide eltrombopag eluxadoline Elvitegravir Elvitegravir BW‑524W91 EMA EMPAGLIFLOZIN Enediynyl Ligands enzyme ERECTILE DYSFUNCTION erectogenic agent. Erismodegib erlotinib ESCITALOPRAM eslicarbazepine acetate EU EU CHMP European Cosentyx Everolimus Evidence-Based Evocalcet EVOFOSFAMIDE EVOGLIPTIN EVT 302 exhaust air relative humidity index (EHI) facility Fadrozole FALDAPREVIR FARXIGA FDA fda 2014 Female Libido Enhancer female viagra Ferrer fertility in women Fidaxomicin filgrastim-sndz filibuvir Filorexant Finds fine particle firm flibanserin flow chemistry Flow Synthesis flu fluticasone furoate FONDAPARINUX Foods Fosamprenavir France Fresolimumab galdansetron Garcinia Cambogia garden cress garlic Gaucher disease gbr 1302 Gilead Gilead. Cobicistat ginger Gisadenafil Gisadenafil for erectile dysfunction glenmark GLIPTIN glycerol phenylbutyrate GMP GOSOGLIPTIN Gossypol GRANISETRON Grela catalyst GS‑7340 GSK GSK 2269557 GSK 2793660 GSK 923295 Guidance H3D Haritaki (Terminalia chebula) Hayashi–Miyaura asymmetric conjugate addition HCV protease inhibitor HDL hepatitis C virus genotype 1 hepatitis drug Herbal Remedies herbs heterocyclic carboxamide high-speed mixer granulator Hikma hiv HIV Infections Hormone Imbalance Hu Zhang Hyderabad Ibrutinib ibuprofen icotinib ICSYNTH Software Tool Idarubicin hydrochloride Idea Generator for Synthesis Prediction Idelalisib Idiopathic Pulmonary Hypertension IDRAPARINUX IkB kinase inhibitors iloprost IMBRUVICA Immunodeficiency Virus in the United States Inc. INDIA India: Going Global Indian Medicinal Plants indoline industrial process influenza virus H5N1 insuman Insys Pharmaceutical internal friction angle Investigational IPRAGLIFLOZIN Iroko Pharmaceuticals IRRITABLE BOWEL SYNDROME Irritated Skin Isis IXABEPILONE ixazomib JAKAFI Jan 2016 Janssen Janssen Pharmaceutical Research & Development L.L.C japan Japanese Knotweed JUBLIA KAE 609 kainic acid KAIXIN Kanuma KEBUZONE KERALA KHAJURAHO KHK 7580 KW-4490 lanepitant LANINAMIVIR Laromustine LATUR LBH589 LEDIPASVIR LESINURAD Letrozole levetiracetam LEVOCETRIZINE LEVOSIMENDAN LEXIPAFANT LIBIDO Lilly LINEZOLID Liquorice liraglutide lixisenatide LODENAFIL Lonza LORCASERIN losartan Loxapine Lu AA21004 lupin LUSEOGLIFLOZIN LY-156735 lysosomal acid lipase (LAL) deficiency macimorelin-acetate MACITENTAN macrocyclization MADYA PRADESH MAHARASHTA malaria Managing Director manufacturing MARIZOMIB medicinal chemistry Medicinal Product Registration Medicinal Properties medicine MELOGLIPTIN merck meropenem Mesothelioma Cancer microencapsulation MIDAZOLAM migraine Mirodenafil MK 6096 MK 7655 MLN-9708 monoclonal antibody Mosquito Bites MOXIFLOXACIN mParkinson’s Disease Mulethi multiple myeloma murine norovirus N-{2-[7-(Cyclohexylmethyl)-1 Nanomedicine NANOPARTICE narlaprevir nce NDA NEMONOXACIN NETUPITANT neudardin NEUROLOGICAL new New 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors in Model of Mood Disorders new drug approvals New Drugs New Malaria Vaccine New Medical Device New Therapeutic Strategy nexavar NITD 609 norovirus Novartis Novel Echinocandin NOXAFIL NVP-BEZ235 NXL104 obinutuzumab ofatumumab olmesartan olodaterol OLOPATADINE Olysio omacetaxine mepesuccinate Omecamtiv mecarbil omega 3s oncology oncology pipeline ondansetron Onrigin organic chemistry ORGANIC SYNTHESIS Organo-Iodine Compounds Analysis Orphan Status OSTEOARTHRITIS Osteoarthritis Pain P2X7 P2X7 receptor antagonists Painkillers Palatin’s palbociclib PALINAVIR palladium complexes PAMICOGREL pan coater panobinostat particle size distribution PATENT EXPIRY PATENTS Patiromer PD-6735 Peptide perifosine Ph.D. is the Director of FDA’s office in India. Pharmaceutical Pharmaceutical Powder PHASE 2 Phase II phase II clinical trials Phase II drug Philippe André phosgene phytohormone PILOT PLANT pimecrolimus Pimples pipeline PIRODAVIR PLANTAIN plants platinum plerixafor Polygonum cuspidatum POLYMORPHISM POLYMORPHS poorly water-soluble drug porous calcium silicate (PCS) posaconazole positive opinion Potent and Improved New Derivatives PPARα pranlukast Preclinical characterization pregabalin Prevent Preventing Primary pulmonary hypertension Printing with Collagen process process modelling process R&D progesterone Proline CCI-779 Promacta PROSTRATE PS 341 psoriasis pumpkin acid PURSLANE qbd Quinocarcin ramelteon RAMOSETRON RAND D Rapamycin rare disease ravicti Recent Advances in Drug Development recombinant von Willebrand factor Red Cedar (Juniperus virginiana) reddys Refractory Indolent Non-Hodgkin’s Lymphoma RELEBACTAM Reliance Life Sciences REMOGLIFLOZIN resistance RG-1577 rhodium catalysis rigosertib ring-closing metathesis Riociguat RIOCIQUAT rivastigmine RO-4602522 roche ROLAPITANT Role root canals Rosa canina Route Design ROW2 TECH roxadustat RPL554 Rufinamide Rupatadine Ruthenium ruxolitinib SAFFRON Salinosporamide A Sanofi Sanofi Pasteur sarilumab sartan SAXAGLIPTIN scalable routes scale up sciclone Scientists SCRIP Awards 2013 Scripps Research Institute sebelipase alfa secukinumab SEMAPIMOD Sembragiline semisynthetic opioids SEP-225289 sergliflozin Sermorelin SEX DRIVE shanghai shear stress Shear Testing Shire side effects SILDANAFIL CITRATE SILDENAFIL Siltuximab simeprevir Singapore Sirolimus SITAGLIPTIN size Size and Shape Matter Sleeping Sickness SMARTCHEM Solamargine solasodine rhamnosyl glycoside Sonidegib sorafenib SOVAPREVIR Spanish fly Spinal Cord Injury Squalamine Sreeni Labs Private Limited Sreenivasa Mundla Reddy St. Jude Children's Research Hospital. Star Anise (Illicium anisatum) stendra sticking sticking index stivarga Strigolactones Striverdi Study Successful Anticancer Drug SUMATRIPTAN sun pharma Supervision SURAMIN surface solid dispersion Suzuki cross-coupling sweden Synribo SYNTHESIS TA3 breast malignancy tablet Tablet Production tablet water content tak 733 TAKEDA Talaglumetad hydrochloride tandospirone tarceva tariquidar tasimelteon TASIMELTION Taxol Tazobactam TCMDC 123812 Tecadenoson TEDIGLUTIDE TEGOBUVIR Telangana Temsirolimus ten lakh views TENELIGLIPTIN teriflunomide tetrahydroquinoxaline tezosentan The 10-Hydroxy-2-Decenoic Acid thioridazine Thymelaea (Thymelaea hirsuta). TIDEGLUSIB Tiger Cane TIK-301 Tivicay Toca 511 Toca FC Tocagen TOPIROXOSTAT TOSEDOSTAT Trabectedin Traditional Chinese medicine TRANDOLAPRIL TRANSVERSE MYLETIS traxoprodil Treat Major Depressive Disorder treat type 2 diabetes Treatment treatment of breast cancer. TRELAGLIPTIN triglycerides Trioxacarcin A Triphala triphosgene TROPISETRON Trulicity Tummalapalli Venkateswara Rao Tumorigenic tumors type 1 diabetes TYROSINE KINASE INHIBITORS UCT Drug Discovery and Development Centre udenafiL umeclidinium Umirolimus UNANI MEDICINE US FDA vaniprevir vedroprevir Vernakalant verona pharma VESTIPITANT VIAGRA vilanterol vimizim vincristine VITAMIN A VITAMINS VNP40101M volasertib Vonvendi VORINOSTAT Vortioxetine ボルチオキセチン Vulvovaginal candidiasis wall friction angle WARNER CHILCOTT Weight Loss Westlake Village wet granulation method WHISKY LACTONE world drug tracker Xalkori XenoPort XL550 xofigo XP-23829 Xuezhikang Yondelis zafirlukast ZANAMIVIR zensun Ziprasidone ZK-96480 ZnT8Ab autoantibody test Zorvolex Zuacta Zucapsaicin β-Lactamase inhibitor شیرین بیان मुलेठी 利西拉布利沙福开心网甘草臭化水素酸塩

MYSELF

Every day drug approvals brought to you in blog section of this site

join me on Linkedin

Anthony Melvin Crasto Ph.D - India | LinkedIn

join me on Researchgate

RESEARCHGATE

LINK CLICK

join me on Facebook

Anthony Melvin Crasto Dr. | Facebook

FACEBOOK

join me on twitter a

Anthony Melvin Crasto Dr. | twitter

Twitter

join me on google plus

Anthony Melvin Crasto Dr. | google plus

GOOGLE PLUS

Dr. Anthony Melvin Crasto, graduated from Mumbai University, Completed his Ph.D from ICT, 1991, Mumbai, India, in the field of Organic Chemistry, Currently he is working with GLENMARK PHARMACEUTICALS LTD, Research Centre as a Principal Scientist, in Process Research at Mahape, Navi Mumbai, India, for the last 10 years, His total Industry experience is 30 +yrs with major Multinationals companies.

Prior to joining Glenmark, he has worked with major multinationals like Hoechst Marion Roussel, now Sanofi, Searle India Ltd, now RPG lifesciences, etc. He has worked with notable Scientists like Dr K Nagarajan, Dr Ralph Stapel, Prof S Seshadri , Dr T.V. Radhakrishnan and Dr B. K. Kulkarni, etc, He did Custom Synthesis for various multinationals in his career like BASF, Novartis, Sanofi, Pfizer etc., He has worked in Drug Discovery, Natural products, Bulk Drugs, Generics, Intermediates, Fine chemicals, Neutraceuticals, GMP, Scaleups, Pharma Plant, API plant etc, he is now helping millions, His friends call him worlddrugtracker.

His New Drug Approvals, All about drugs, Eurekamoments, Organic spectroscopy international, etc in Organic/ Medchem are some most read blogs. He has hands on experience in initiation and developing Novel routes for Drug molecules and implementing them on commercial scale over a 30 year tenure till date Feb’ 2018, Around 30 plus commercial products in his career. He has good knowledge of IPM, GMP, QbD, Regulatory aspects, Technology transfer, Manufacturing, Formulations, Spectroscopy, Stereochemistry, Synthesis, Polymorphism etc. He has several International patents published worldwide.

He suffered a one in a million disease in the form of a paralytic stroke/ Acute Transverse Mylitis in Dec’ 2007 and is 90 % paralysed, He is bound to a wheelchair, this seems to have injected feul in him to help chemists all around the world, he is more active than before and is pushing boundaries, he has several million hits on Google, 60 Lakh plus views on dozen plus blogs, He makes himself available to all, contact him on +91 9323115463, email amcrasto@gmail.com, Twitter, @amcrasto

He is a prolific presenter and is invited to major conferences in Mumbai, where he can travel easily. He speaks at universities on topics of Drug discovery, Patents, Qbd, GMP, Tech transfer, polymorphism, Literature search tools, Computer programs and Topics of interest to Pharma Students.

His extraordinary skill on the Computers give him the edge to write/present his thoughts. He demonstrates them to students and professionals alike.

Notably he has 20 lakh plus views on New Drug Approvals Blog in 216 countries, This blog has 3.5 lakh viewers in USA alone.

Awards

"100 Most Impactful Health care Leaders Global listing", conferred at Taj lands end, Mumbai, India on 14 Feb 2017 by World Health Wellness congress and awards

“Best Worlddrugtracker “ Award for lifetime acheivement in Pharma... 7 th July 2017 , The venue...Taj land ends, Bandra, Mumbai India

“Lifetime achievement award” WORLD HEALTH CONGRESS 2017 in Hyderabad, 22 aug 2017 at JNTUH KUKATPALLY. HYDERABAD, TELANGANA, INDIA,

" Lifetime Achievement Award", at the The Middle East Healthcare Leadership Awards - 12th October, 2017 -The Address, Dubai Mall, Dubai...UAE..........Mohammed Bin Rashid Boulevard, Downtown Dubai - Dubai - United Arab Emirates

International award for Outstanding contribution in Pharma at World Health and wellness Congress award, 14th Feb, 2018, at Taj Lands ends, Bandra, Mumbai, India

Conferred very prestigious IDMA award for contribution to society in Pharma at INDIAN DRUGS ANNUAL DAY 2018 VMCC IITBombay Powai, Mumbai India 22 Feb 2018,I was Guest of honor at and was felicitated by president,Indian Drug manufacturers association (IDMA)

Award conferred The Golden Globe Tigers Awards 2018, for Excellence in Pharma, at kuala lumpur, Malaysia, 23 april 2018 at Pullman hotel.

Conferred prestigious individual national award at function for contribution to Pharma society from Times Network, National Awards for Marketing Excellence ( For Excellence in HEALTHCARE) | 5th July, 2018 | Taj Lands End, Mumbai INDIA

Conferred award for Excellence in Pharma by CMO ASIA Award 31st July - 1st August, 2018 | Le Méridien Singapore, Sentosa

Life time Achievement Award by Bioleagues at 4th World Summit on Pharmaceutics Drug Designs, Dubai, UAE. Sep 21-22, 2018 at Flora creek Dubai UAE

Conferred prestigious ABPnews award for "Outstanding contribution to Education Sector" at event ABP News Presents Healthcare Leadership Awards 26th November, 2018 at Taj Lands End, Mumbai India

Honoured to get Award by ETnow for Outstanding contribution to social service at ET Now Presents World Mental Health Congress Co - Hosted with World Health & Wellness Awards, 15th February, 2019. | Taj Lands End, Mumbai, India

Honoured to get prestigious "SPER Innovative Researcher Award" The award was given in the SPER 8th Annual International Conference & Exhibition [SPER 2019] at VYWS’S Inst of pharma education and Research, Wardha [Maharashtra] India on February 23, 2019

Biography

READ MY BIOGRAPHY..........http://scijourno.com/2017/01/09/dr-anthony-crasto/ Written by Mr. Amrit B. Karmarkar
Director, InClinition

DR ANTHONY MELVIN CRASTO Ph.D , Born in Mumbai in 1964 and graduated from Mumbai University, Completed his PhD from ICT ,1991, Mumbai, India in Organic chemistry, The thesis topic was Synthesis of Novel Pyrethroid Analogues,

Currently he is working with GLENMARK PHARMA LTD, Research centre as Principal Scientist, Process Research (bulk actives) at Mahape, Navi Mumbai, India.

Prior to joining Glenmark, he worked with major multinationals like Hoechst Marion Roussel, now Sanofi Aventis, & Searle India ltd, now RPG lifesciences, etc. He has worked in Basic research, Neutraceuticals, Natural products, Flavors, Fragrances, Pheromones, Vet Drugs, Drugs, formulation, GMP etc. He has total 30 yrs exp in this field, he is now helping millions, has million hits on google on all organic chemistry websites.

His New Drug Approvals , Green Chemistry International, Eurekamoments in Organic Chemistry , Organic Chemistry Select, WIX BLOG , ALL ABOUT DRUGS, WORLD DRUG TRACKER, MEDICINAL CHEM INTERNATIONAL, DRUG SYN INTERNATIONAL,SCALEUP OF DRUGS, ALL FOR DRUGSON WEB, are some most read chemistry blogs

SEE

Green Chemistry International,
ORGANIC SPECTROSCOPY INTERNATIONAL
ORGANIC SYNTHESIS INTERNATIONAL
ORGANIC CHEMISTRY INTERNATIONAL
DR ANTHONY MELVIN CRASTO OLD BLOG
DRUG PATENTS INTERNATIONAL
Organic Chemistry Select,
Drug regulatory affairs international
ONE ORGANIC CHEMIST ONE DAY
API SYNTHESIS INTERNATIONAL
DRUG APPROVALS INTERNATIONAL

MEDIA

RESEARCHGATE, LINKEDIN, SLIDESHARE, ACADEMIA.EDU, GOOGLE PLUS, FACEBOOK, TWITTER, GRAVATAR, YOUTUBE,

He has hands on experience in initiation and developing novel routes for drug molecules and implementation them on commercial scale over a 30 year tenure, good knowledge of IPM, GMP, Regulatory aspects, he has several international drug patents published worldwide .

He has good proficiency in Technology Transfer, Spectroscopy , Stereochemistry , Synthesis, Reactions in Org Chem , Polymorphism, Pharmaceuticals , Medicinal chemistry, Organic chemistry literature , Patent related site , Green chemistry , Reagents , R & D , Molecules , Heterocyclic chem ,Sourcing etc

He suffered a paralytic stroke in dec 2007 and is bound to a wheelchair, this seems to have injected feul in him to help chemists around the world, he is more active than before and is pushing boundaries, he has 2.5 lakh connections on all networking sites, He makes himself available to all, contact him on +91 9323115463, amcrasto@gmail.com, Twitter @amcrasto

SEE MY CHINA, VIETNAM AND JAPAN BLOGS

http://amcrasto.blog.fc2.com/

http://blog.sina.com.cn/u/5030268874

http://ameblo.jp/medchem-amcrasto/

http://me.zing.vn/u/amcrasto

ICELAND, RUSSIA, ARAB

BOBRDOBR, BLAND ICELAND, 100ZAKLADOK, ADFTY, CLOOB

GROUPS

You can post articles and will be administered by me on the google group which is very popular across the world, OPD GROUPSPACES, SCOOP OCI, organic-process-developmentGOOGLE, TVINX, MENDELEY WDT,SCIPEOPLE OPD, EPERNICUS OPD, SYNTHETIC ORGANIC CHEMISTRYLinkedIn group, DIIGO OPD,LINKEDIN OPD, WDT LINKEDIN, WDTI ZING,WORLD DRUG TRACKER FACEBOOK

ALSO web link

ABOUTME, BRAND ANTHONYCRASTO, ANTHONY M CRASTO weebly, Anthony M Crasto Strikingly, COLLECTION OF SITE LINKS, BRAVESITES, JIMDO, SKILLPAGES, MIXXT,APNACIRCLE, ZIC ZAC, ZING ME, SCOOP IT, SCRIBD, STUMBLEUPON, DELICIOUS, PININTEREST, TUMBLIR, NEWSVINE, ISSUU,DIIGO, YOLASITE, RESEARCHGATE, LINKEDIN, SLIDESHARE, ACADEMIA.EDU, GOOGLE PLUS, FACEBOOK, TWITTER, GRAVATAR,AUTHORSTREAM, SYMBALOOO, ISSUU, BLOGLOVIN,FRIENDFEED,NEWSVINE, TREPUP, XING, TIXXT, YOUTUBE, JUJUJU,

Sr no	blog	Hits LAKHS	link	remarks
1	New Drug Approvals ,	20	https://newdrugapprovals.org/	218 countries
	ORGANIC SPECTROSCOPY INTERNATIONAL	10	https://orgspectroscopyint.blogspot.in/
3	API SYNTHESIS INTERNATIONAL	1.8	http://apisynthesisint.blogspot.in/
4	ONE ORGANIC CHEMIST ONE DAY	2,4	http://oneorganichemistoneday.blogspot.in/
5	WORLD DRUG TRACKER	3.8	http://worlddrugtracker.blogspot.in/
6	MEDICINAL CHEM INTERNATIONAL	2,2	http://medcheminternational.blogspot.in/
7	ALL ABOUT DRUGS	1.6	http://www.allfordrugs.com/
8	DRUG PATENTS INTENATIONAL	1.8	http://drugpatentsint.blogspot.in/
9	Green Chemistry International,	0.11	https://greenchemclips.wordpress.com/
10	Drug regulatory affairs international	0.87	https://amcrasto.wordpress.com/
11	Organic Chemistry Select	0.55	https://anthonycrasto.wordpress.com/
12	ORGANIC CHEMISTRY INTERNATIONAL	1.87	http://organicchemistrysite.blogspot.in/
13	ORGANIC SYNTHESIS INTERNATIONAL	2.34	http://organicsynthesisinternational.blogspot.in/
14	DRUG APPROVALS INTERNATIONAL	0.11	http://drugapprovalsint.com/
15	Eurekamoments in Organic Chemistry ,	0.5	http://amcrasto.theeurekamoments.com/
16	WIX BLOG ,	0.2	http://amcrasto.wix.com/anthony-melvin-crasto/apps/blog
17	ALL FOR DRUGSON WEB,		http://amcrasto.webs.com/

		50 plus